| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20008492 | HPV | ENSG00000170231.16 | protein_coding | FABP6 | No | No | 2172 | P51161 |
| TVIS20029789 | HPV | ENSG00000170231.16 | protein_coding | FABP6 | No | No | 2172 | P51161 |
| TVIS20030383 | HPV | ENSG00000170231.16 | protein_coding | FABP6 | No | No | 2172 | P51161 |
| TVIS20060172 | HPV | ENSG00000170231.16 | protein_coding | FABP6 | No | No | 2172 | P51161 |
| TVIS44025477 | HTLV-1 | ENSG00000170231.16 | protein_coding | FABP6 | No | No | 2172 | P51161 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | FABP6 |
|---|---|
| DrugBank ID | DB04348 |
| Drug Name | Taurocholic acid |
| Target ID | BE0001967 |
| UniProt ID | P51161 |
| Regulation Type | ligand |
| PubMed IDs | 30559664; 12486725 |
| Citations | Ethanic M, Stanimirov B, Pavlovic N, Golocorbin-Kon S, Al-Salami H, Stankov K, Mikov M: Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Front Pharmacol. 2018 Dec 3;9:1382. doi: 10.3389/fphar.2018.01382. eCollection 2018.@@Kurz M, Brachvogel V, Matter H, Stengelin S, Thuring H, Kramer W: Insights into the bile acid transportation system: the human ileal lipid-binding protein-cholyltaurine complex and its comparison with homologous structures. Proteins. 2003 Feb 1;50(2):312-28. |
| Groups | Approved; Experimental |
| Direct Classification | Trihydroxy bile acids, alcohols and derivatives |
| SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@]12C)[C@H](C)CCC(=O)NCCS(O)(=O)=O |
| Pathways | Congenital Bile Acid Synthesis Defect Type II; Familial Hypercholanemia (FHCA); Bile Acid Biosynthesis; Zellweger Syndrome; Congenital Bile Acid Synthesis Defect Type III; 27-Hydroxylase Deficiency; Cerebrotendinous Xanthomatosis (CTX) |
| PharmGKB | |
| ChEMBL | CHEMBL224867 |
